The information contained here is purely for informational purposes and does not, in any event, seek to take the place of a consultation with a medical professional. In the event of doubt or if you have symptoms, you should always consult a medical professional.
Expanded Access or Right to Try in the United States:
PharmaMar currently does not offer an Expanded Access Program or offer patients the ‘Right to Try’ for either Lurbinectedin or Plitidepsin or any other investigational drug for any indication in the United States. Such policy may be reviewed and changed in the future. However on a case-by-case basis, PharmaMar considers requests from US-licensed treating physicians for access to the investigational product, lurbinectedin, for patient treatment purposes. Treating physicians may request more information by contacting PharmaMar at firstname.lastname@example.org. Reply to a request for information will be acknowledged as soon as possible.